1 Product identity
Adreno - Lyph - Sym
Other Combinations Tablet or Pill 14 ingredients DSLD #27522Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-11-25
2 Ingredients (14)
IngredientGroupSafety
Vitamin B1Thiamin—
Vitamin B6Vitamin B6—
Bioflavonoid ComplexBlend (Combination)—
231 mg tissue concentrateBovine (unspecified)—
AdrenalAdrenals—
PituitaryPituitary—
ParotidParotid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Riboflavin — Generally Safe
⚠ Harmless yellow urine
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
Biotin — Generally Safe
⚠ Interferes with troponin and thyroid lab assays
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
L-Methionine — Conditionally Safe
⚠ Raises homocysteine levels
⚠ May promote tumor growth
4 Label claims
• All Other
5 Data source
DSLD ID27522
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-11-25
6 More from Nutri-West
View Nutri-West Safety Scorecard → 186 products
#1 - AD#2 - CFAdreno-Lyph 80Adreno-Lyph-160Adreno-Lyph-ParaAdreno-Lyph-Plus7 Cite this page
Vancouver
Pkhakadze G. Adreno - Lyph - Sym — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/adreno-lyph-sym-27522/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG